Stocks and Investing
Stocks and Investing
Wed, August 14, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Raghuram Selvaraju Reiterated (ABEO) at Strong Buy and Held Target at $15 on, Aug 14th, 2024
Raghuram Selvaraju of HC Wainwright & Co., Reiterated "Abeona Therapeutics Inc." (ABEO) at Strong Buy and Held Target at $15 on, Aug 14th, 2024.
Raghuram has made no other calls on ABEO in the last 4 months.
There are 2 other peers that have a rating on ABEO. Out of the 2 peers that are also analyzing ABEO, 0 agree with Raghuram's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Raghuram
- Dae Gon Ha of "Stifel" Initiated at Strong Buy and Held Target at $21 on, Thursday, May 30th, 2024
- Kristen Kluska of "Cantor Fitzgerald" Maintained at Buy with Decreased Target to $21 on, Thursday, May 16th, 2024
Contributing Sources